Ivermectin debacle exposes flaws in meta-analysis methodology
By 
Anthony King2021-09-29T13:30:00
Health researchers warn that taking studies at face value is a luxury that they can no longer afford
Evidence that anti-parasitic drug ivermectin can save lives in Covid-19 cases has gone up in smoke. Key studies have been deemed suspect or downright fraudulent.
Supporters of this anti-parasitic drug pointed to a meta-analysis from the University of Liverpool, which reported that the death rate in those taking ivermectin was 56% lower, but this is now rejected by those who led the study.